We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company will pay $11.5 million to resolve allegations that it caused false claims to be submitted to government healthcare programs for procedures involving an unapproved drug-delivery device. Read More
The device uses magnetized particles to guide the biopsy procedure, with the magnetic particles traveling to lymph nodes and becoming trapped there, allowing magnetic detection of the nodes. Read More